|
|
Volumn 8, Issue 4, 2005, Pages 244-249
|
|
Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
FLUINDOSTATIN;
FLUOROBENZENE;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INDOLE DERIVATIVE;
MEVINOLIN;
MONOUNSATURATED FATTY ACID;
PRAVASTATIN;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
ROSUVASTATIN;
SIMVASTATIN;
SULFONAMIDE;
CHRONIC KIDNEY FAILURE;
COMORBIDITY;
DYSLIPIDEMIA;
HUMAN;
KIDNEY TRANSPLANTATION;
REVIEW;
COMORBIDITY;
DYSLIPIDEMIAS;
FATTY ACIDS, MONOUNSATURATED;
FLUOROBENZENES;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INDOLES;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
LOVASTATIN;
PRAVASTATIN;
PYRIMIDINES;
PYRROLES;
SIMVASTATIN;
SULFONAMIDES;
|
|
EID: 32944474036
PISSN: 1520037X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.0197-3118.2005.04078.x Document Type: Review |
|
Times cited : (11)
|
|
References (64)
|
